Recruiting

ESAN II - Energy Sensing in Depression

The purpose of this study is to assess the effects of polyphenols from natural aronia juice on the immune system. Therefore, the study aims to distinguish the effects of natural juices that are rich in phytonutrients such as polyphenols and carotenoids in healthy and depressive subjects in order to use the known positive effects of these food sources in the therapeutic setting. The consumption of natural fruit juices that are rich in polyphenols and carotenoids mirror a model of vegetarian diet due to the…

I'm interested View official listing
ClinicalTrials.gov IDNCT05432362
PhaseNA
Enrollment120
SponsorMedical University of Graz
Age18 Years – 40 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Immune System Tolerance, Depression, Obesity, Microbial Colonization, Diet, Healthy

About this study

The purpose of this study is to assess the effects of polyphenols from natural aronia juice on the immune system. Therefore, the study aims to distinguish the effects of natural juices that are rich in phytonutrients such as polyphenols and carotenoids in healthy and depressive subjects in order to use the known positive effects of these food sources in the therapeutic setting. The consumption of natural fruit juices that are rich in polyphenols and carotenoids mirror a model of vegetarian diet due to the increased micronutrient density derived from plant food. Results obtained here can be seen as preliminary explanation models for the beneficial effects of vegetarian diet. It is hypothesized, that the consumption of naturally polyphenol rich aronia juice changes the expression of regulatory T cells, specific cells of the immune system that contribute to immunomodulation. Furthermore, beneficial changes in the gut microbiome, the metabolome and the nutritional status are expected in the studied groups. The study was registered retrospectively (after start of recruitment) on Clinicaltrials.gov.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: 1. Socio-demographic criteria: 1. Gender: female 2. Age: 18-40 years 2. Confirmation of the study settings 1. receives of information on * the aims, * methods, * anticipated benefits, * potential risks, and * entailed discomforts of the study 2. signed declaration of consent 3. Subgroup of depressive patients: 1. diagnosis of depression according to the ICD-10 criteria for depression 2. diagnosed by an experienced psychiatrist * a structured diagnostic interview * voluntarily agreement to participate * signed informed consent 4. Subgroup of normal weight participants: * WHO criteria for normal weight (body mass index (BMI) 18.5-24.99 kg/m2) 5. Subgroup of obese participants * WHO criteria for obesity (BMI \< 30.0 kg/m2) Exclusion Criteria: 1. Formal criteria: * lack of informed consent 2. Health criteria 1. alcohol- or drug abuse 2. major cognitive deficits (which do not allow adequate testing) * according to Mini Mental Status Examination (MMSE) \<20 3. patients which are currently in the locked ward of the clinic 4. acute or chronic diseases or infections within the previous two months * upper respiratory tract infections * fever * chronic inflammatory disorders * autoimmune-disorders * blood diseases * mitochondrial diseases 3. Digestive disorders 1. fructose intolerance 2. history of digestive diseases such as * inflammatory bowel disease * irritable bowel syndrome 3. treatment that may has influenced the microbiome * antibiotic or antifungal treatment within the previous two months * daily or irregular intake of prebiotics or probiotics within the previous two months (the intake of yoghurt and dairy products are permitted) 4. history of gastrointestinal surgery (other than appendectomy) 4. Pregnancy and period of breastfeeding

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-12.